The Commission of the Ministry of Health of the Russian Federation on the formation of lists of drugs recommended two drugs for the treatment of multiple sclerosis to be included in the lists of 14 VDN and VED: divosilimab and sampeginterferon beta-1a (Protocol dated February 8, 2024). Link to the document on the website of the Ministry of Health of the Russian Federation protocol_08.02.2024.pdf (minzdrav.gov.ru)